25+ years of successful track record in new drug R&D, commercialization, corporate development, and strategic planning.
VP of Commercial Development at Boston Scientific, responsible for commercialization, business and strategic development in the Asia Pacific region including Greater China.
Scientist at ICOS Corporation and contributed to the development of Cialis® for treatment of erectile disfunction. After facilitating the formation of Lilly/ICOS JV, led the clinical pharmacology function to the approval of Cialis® by FDA.
Co-founder of Endocyte (later acquired by Novartis).
Ph.D. in Biochemistry from Purdue University, USA. BS in chemistry from Fudan University.